Rigel Pharmaceuticals RIGL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.47M-39.8% | $40.64M-16.3% | $48.53M-9.1% | $53.41M+16.6% | $45.79M-19.3% | ||
| $122.27M+6.9% | $114.38M+29.1% | $88.61M+61.2% | $54.97M+75.2% | $31.37M+52.5% | ||
| $49.95M-3.5% | $51.76M+12.7% | $45.93M+15.1% | $39.91M-3.9% | $41.55M-0.2% | ||
| $11.65M+1.3% | $11.51M-13.5% | $13.3M+27.6% | $10.42M+124% | $4.66M-22.4% | ||
| $234.03M-2.6% | $240.17M+11.7% | $214.93M+22.5% | $175.39M+19.7% | $146.56M+8.5% | ||
| $24.16M-2.4% | $24.75M-2.3% | $25.34M-2.3% | $25.92M-2.2% | $26.51M-2.2% | ||
| $24.16M-2.4% | $24.75M— | —— | —— | —— | ||
| $504.61M-1.7% | $513.59M+112% | $242.53M+17.3% | $206.74M+17.5% | $175.97M+7.3% | ||
| $4.49M-37.6% | $7.19M+87.0% | $3.85M-47.2% | $7.29M+84.4% | $3.95M+18.4% | ||
| $22.5M-25.0% | $30M— | —— | —— | —— | ||
| $89.49M-9.8% | $99.24M+5.1% | $94.4M+9.0% | $86.64M+30.0% | $66.63M+5.3% | ||
| $45M-14.3% | $52.5M— | —— | —— | —— | ||
| $104.71M-14.3% | $122.11M-2.3% | $124.93M+0.1% | $124.8M-20.7% | $157.41M-2.0% | ||
| $18K0.0% | $18K0.0% | $18K0.0% | $18K0.0% | $18K-100.0% | ||
| -$1.01B+0.8% | -$1.02B+20.8% | -$1.29B+2.1% | -$1.32B+4.3% | -$1.38B+0.8% | ||
| $399.9M+2.2% | $391.48M+233% | $117.61M+43.5% | $81.93M+341% | $18.57M+465% | ||
| $504.61M-1.7% | $513.59M+112% | $242.53M+17.3% | $206.74M+17.5% | $175.97M+7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rigel Pharmaceuticals's total assets?
- Rigel Pharmaceuticals (RIGL) holds $504.6M in total assets, up 186.8% year over year.
- How much debt does Rigel Pharmaceuticals have?
- Rigel Pharmaceuticals carries $68.4M in total debt against $399.9M of shareholders' equity, a debt-to-equity ratio of 0.17.
- How much cash does Rigel Pharmaceuticals have?
- Rigel Pharmaceuticals holds $24.5M in cash and equivalents.
- Can Rigel Pharmaceuticals cover its short-term obligations?
- Its current ratio is 2.62 — current assets exceed current liabilities.
- Where does Rigel Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
